The Beauty Health Company
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- The Beauty Health Company The Beauty Health Company (Nasdaq: SKIN), together with its subsidiaries, designs, develops, manufactures, markets and sells esthetic technologies and skincare products focused on non-invasive aesthetic treatments worldwide, including in the Americas, Asia-Pacific, Europe, the Middle East and Africa; the company's flagship HydraFacial system utilizes patented vortex-fusion technology to cleanse, extract, exfoliate and hydrate skin through customizable proprietary serums and boosters addressing concerns such as acne, fine lines, hyperpigmentation and dryness; complementary offerings include Syndeo delivery systems for personalized provider-consumer experiences, SkinStylus SteriLock Microsystem for microneedling and nanoneedling treatments targeting hypertrophic scars and acne in Fitzpatrick skin types I-III, Keravive peptide solutions and take-home sprays for scalp health optimization, single-use consumables comprising treatment tips, solutions and serums that represent over 70% of revenue, and the MyBeautyHealth mobile application enabling consumer loyalty points, personalized skin plans and provider connections. Founded in 1997 and headquartered at 2165 Spring Street in Long Beach, California, the company targets skincare professionals, medspas, salons and consumers seeking science-backed beauty health experiences in the consumer staples sector's household and personal products industry. Recent developments include the successful launch of HydraFillic with Pep9 Booster and Hydralock HA boosters driving 14% consumables growth and contributing to gross margin expansion to 64.6% in Q3 2025, substantial debt reduction of approximately $189 million in convertible senior notes through refinancing and repurchases to bolster the balance sheet with $219 million in cash equivalents as of September 30 2025, updated FY2025 guidance raising net sales projections to $293-$300 million and Adjusted EBITDA to $37-$39 million amid an active install base of 35,409 delivery systems, transition to a direct distributor model in China to streamline inventory and mitigate tariff exposure, and manufacturing optimizations alongside cost discipline yielding Adjusted EBITDA of $8.9 million in Q3 2025 despite softer device placements.
Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health
Why SkinHealth Systems Inc. (SKIN) International Revenue Trends Deserve Your Attention
Beauty Health Q1 Earnings Call Highlights
SkinHealth Systems Inc. (SKIN) Q1 2026 Earnings Call Transcript
SkinHealth Systems Inc. (SKIN) Reports Q1 Loss, Lags Revenue Estimates
Compared to Estimates, SkinHealth Systems Inc. (SKIN) Q1 Earnings: A Look at Key Metrics
SkinHealth Systems Reports First Quarter 2026 Financial Results
SkinHealth Systems Inc. (SKIN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The Estée Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN
SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026
SkinHealth Systems Inc. Appoints Three New Independent Directors to Board
The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform
Don't Overlook Beauty Health (SKIN) International Revenue Trends While Assessing the Stock
The Beauty Health Company (NASDAQ:SKIN) Receives Consensus Rating of “Reduce” from Brokerages
The Beauty Health Company (SKIN) Q4 2025 Earnings Call Transcript
Beauty Health (SKIN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The Beauty Health Company (SKIN) Reports Q4 Loss, Tops Revenue Estimates
BeautyHealth Reports Full Year and Fourth Quarter 2025 Financial Results
Unveiling Beauty Health (SKIN) Q4 Outlook: Wall Street Estimates for Key Metrics
Beauty Health (SKIN) Projected to Post Quarterly Earnings on Thursday